A Multicenter phase II study of Carboplatin/Pemetrexed/Bevacizumab in First-Line Treatment of Elderly Patients with Advanced Non-squamous and Non-small Cell Lung cancer - Phase II study of CBDCA/PEM/BEV in elderly NSCLC

Kurume University School of Medicine0 个研究点目标入组 42 人开始时间: 2013年7月2日最近更新: 2023年10月17日

研究概览

暂无简介。

•1) The case that there is previous treatment history 2) With the active double primary cancer 3) With the pleural effusion or pericardial effusion to need drainage 4) With the metastatic brain tumor to need treatment, such as radiotherapy or steroid 5) History of active hemoptysis with 2,5 ml or more 6) The case that a hemorrhage risk is high a) With the necessity of the administration of anticoagulant and antiplatelet agent b) With the the tumor invasion to great vessels c) With the cavity lesion 7) With the following complication or past history a) With the merger or history of cerebrovascular disease to need treatment b) With the history of perforation gastrointestinal, fistula, diverticulitis c) With the diarrhea, paresis of intestine, ileus d) With the merger or history of angina or myocardial infarction, cardiac failure to need treatment e) With the uncontrol diabetes f) With the interstitial pneumonia g) With the uncontrol infectious disease h) With the history of serious drug allergy i) With the uncontrol hypertension even if taking the hypotensive drug 8) With the mental disease 9) The patient whom attending physician judged to be inadequate to perform the study treatment safely

发起方

Kurume University School of Medicine